
Paul Scherrer Institut
Switzerland's largest research institute for natural and engineering sciences, operating unique large-scale research facilities. Excellence in materials science, energy and environment research, and human health applications.
213
Patents
415
Inventors
17
Spin-offs
Analysis of our organization's intellectual property assets
Total Patents
213
Recent Patent Publications (2025 & 2026)
-
Top Inventors
Patent Portfolio
Discover our latest patented technologies
This patent describes a flexible method and system for producing hydrogen and/or methanol using a single fluidized bed reactor. Carbon-rich feedstocks such as biomass or waste are gasified or pyrolyzed to produce a gas mixture that is then catalytically converted in the reactor. By adjusting the operating conditions (such as temperature, pressure, type of catalyst, or addition of reactants), the system can switch between producing hydrogen, methanol, or even methane. The system also allows recovery of carbon dioxide for potential sequestration and can adapt to varying market and energy needs, including integration with renewable energy sources and external hydrogen.
This patent describes a novel, environmentally friendly method for recovering phosphorus and metal ions from dilute aqueous sources like wastewater and industrial effluents, using specially designed cementitious adsorbents (including ettringite). The process works at room temperature, does not require strong acids, incineration, or high temperatures, and achieves high purity recovery of phosphorus, which can be reused as phosphoric acid or as fertilizers like struvite. The process follows a circular economy approach by recycling adsorbent materials internally and is compatible with existing water treatment systems.
This invention describes the use of metal- or metalloid-containing ketoacidoximate compounds as patterning agents (specifically, advanced photoresist materials) for photolithography and electron beam lithography. These novel resists are particularly suitable for extreme ultraviolet (EUV) and electron beam patterning, providing high resolution, high sensitivity, and robust pattern fidelity. The resist materials can be tailored by modifying their organic and inorganic components, making them versatile for advanced semiconductor manufacturing and direct patterning of functional materials.
Success Stories
Companies founded based on our organization's technologies
Focal Biosciences AG develops AI-driven chromatin reprogramming technologies to reverse and cure chronic diseases.
Tandem Therapeutics is a Swiss biopharmaceutical company developing precision therapies targeting the extracellular matrix to treat fibrotic diseases.
XRnanotech is a Swiss deep-tech company specializing in advanced X-ray optics and nanotechnology, delivering high-precision nanostructures and optics for scientific, industrial, and commercial applications.
The PSI Technology Transfer team is ready to assist you with licensing inquiries and collaboration opportunities
Phone
+41 56 310 27 21
techtransfer@psi.ch
Address
Forschungsstrasse 111 5232 Villigen PSI Switzerland
Office Hours
Mo-Fr: 9 – 17 Uhr (allg.)